Related Experiment Video

Updated: Aug 15, 2026

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
10:50

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo

Published on: March 26, 2019

EBV-driven Gate-License-Amplify circuit in multiple sclerosis pathogenesis

Yuxin Li1,2,3, Xiaofei Shi4, Yuxiao Zhang3

  • 1School of Management & Engineering, Nanjing University, Nanjing, China.

Signal Transduction and Targeted Therapy
|August 13, 2026
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis
09:01

Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis

Published on: November 17, 2020

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis
05:55

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis

Published on: December 1, 2023

Related Experiment Videos

Last Updated: Aug 15, 2026

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
10:50

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo

Published on: March 26, 2019

Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis
09:01

Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis

Published on: November 17, 2020

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis
05:55

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis

Published on: December 1, 2023

Related Concept Videos

Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...

Articles linked to this work by shared authors, journal, and citation graph.

Low-protein diet enhances antitumor immunity in pancreatic cancer through microbiota-derived UDP-galactose.

Nature cancer·2026

Latent profiles of kinesiophobia and associated factors in patients with rheumatoid arthritis: a cross-sectional study.

Frontiers in medicine·2026

Association Between Serum ANGPTL8 Levels and PCOS and Its Clinical Utility in Diagnosis.

The journal of obstetrics and gynaecology research·2026

A novel small molecule inhibitor targeting KHSRP methylation suppresses colon cancer progression.

Acta pharmaceutica Sinica. B·2026

Epstein-Barr Virus-Associated HMGB1-Extracellular Vesicles Facilitate Macrophage PD-L1 Expression and Tumor Metastasis.

Head & neck·2026

Genetic Variation of HPV53 and the Identification of T-Cell Epitopes.

Microorganisms·2026

A multicohort, biomarker-driven phase 2 trial of personalized total neoadjuvant therapy with targeted agents for high-risk rectal cancer (The TRAINER study).

Signal transduction and targeted therapy·2026

Harnessing macrophage signaling pathways and scalable engineering for next-generation immunotherapies.

Signal transduction and targeted therapy·2026

Fructose directly remodels the translocase of the outer membrane to impair oxidative phosphorylation in podocytes.

Signal transduction and targeted therapy·2026

Oral nonpeptide GLP-1 receptor agonist VCT220 for obesity treatment: a randomized, double-blind, phase II trial.

Signal transduction and targeted therapy·2026

Mefatinib versus gefitinib as a first-line treatment for EGFR-mutated non-small cell lung cancer: a randomized, double-blind, multicenter phase III study.

Signal transduction and targeted therapy·2026

From probe to prodrug: immunoproteasome activity as a trigger for disease-selective therapeutics.

Signal transduction and targeted therapy·2026

Flexible bioelectronic electrodes: From engineering strategies to cross-domain biomedical applications.

Biosensors & bioelectronics·2026

Long-Term Electrophysiologic Comorbidities After Anatomically Repaired Congenitally Corrected Transposition of the Great Arteries: Atrial Tachyarrhythmias.

JACC. Clinical electrophysiology·2026

Functional Substrate Mapping and Its Correlation With Ventricular Tachycardia Critical Sites: A Blinded Study.

JACC. Clinical electrophysiology·2026

Fine Ventricular Fibrillation Therapy Assurance Algorithm Failure From Low-Amplitude Far-Field Signals: Precision Sensing Strategy.

JACC. Case reports·2026

Efficient Interfacial Electron Modulation Coupled with Machine Learning for Intelligent Microfluidic Photoelectrochemical-Electrochromic Sensing of Tetracycline.

Analytical chemistry·2026

Engineering Multiscale Biohybrid Interfaces for Signal Sensing and Functional Regulation of Electronic Plants.

Advanced materials (Deerfield Beach, Fla.)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us